phase 1_initiation
saveEgyptian International Pharmaceuticals Industries Co SAE — enoxaparin sodium biosimilar (Phase I Trial Initiation)
community read0 votes
Therapy area: Cardiovascular. Indication: Acute Coronary Syndrome, Congestive Heart Failure (Heart Failure), Deep Vein Thrombosis (DVT), Myocardial Infarction, Pulmonary Embolism, Thromboembolic Disease, Thromboembolism, Thrombosis, Unstable Angina, Venous (Vein) Thrombosis, Venous Thromboembolism
Data sources
globaldata
Found something off?
🐶 often sniffed alongside
top 7- tagHeart Failure3 co-mentions · 1 sources
- tagCardiology3 co-mentions · 1 sources
- tagBiosimilar1 co-mentions · 1 sources
- drugenoxaparin sodium1 co-mentions · 1 sources
- companyEgyptian International Pharmaceuticals Industries Co SAE1 co-mentions · 1 sources
- tagPulmonology1 co-mentions · 1 sources
- drugENOXAPARIN SODIUM (PRESERVATIVE FREE)1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that